ZOM Stock Quote
| Symbol: | ZOM |
|---|---|
| Quote: | 0.10 |
| Change: | +-0.00 |
| Change %: | -0.21% |
| High: | 0.10 |
| Low: | 0.09 |
| Open: | 0.09 |
|---|---|
| Volume: | 790,936 |
| 52 Week: | 0.02-0.20 |
| P/E Ratio: | -1.62 |
| EPS: | -0.06 |
| Market Cap: | 95.35 M |
Company Report
Zomedica Corp. is a pioneering veterinary health company dedicated to addressing the unique challenges faced by clinical veterinarians through the development of advanced products for companion animals. At the core of its mission is the TRUFORMA platform, a revolutionary point-of-care diagnostic tool designed to detect various disease states in dogs and cats swiftly. In addition to diagnostic innovations, Zomedica Corp. offers PulseVet, a cutting-edge therapy system that effectively treats musculoskeletal issues such as broken bones, tendonitis, and torn ligaments in both horses and small animals.
The company actively collaborates with industry leaders like Celsee, Inc., focusing on the development and commercialization of liquid biopsy assays. These assays and related consumables are pivotal in detecting cancer early in companion animals, enhancing diagnostic capabilities and treatment outcomes. Further expanding its technological footprint, Zomedica Corp. partners with Seraph Biosciences, Inc. to introduce a novel pathogen detection system that promises to set new standards in veterinary diagnostics.
Founded in 2015 and headquartered in Ann Arbor, Michigan, Zomedica Corp. has evolved significantly since its inception as Zomedica Pharmaceuticals Corp., rebranding in October 2020 to reflect its broader commitment to advancing veterinary care. With a forward-thinking approach and a strong emphasis on innovation, Zomedica Corp. continues to push boundaries in veterinary medicine, aiming to improve the health and well-being of companion animals globally.
ZOM EPS Chart
ZOM Revenue Chart
ZOM Profile
| Exchange: | AMEX |
|---|---|
| Beta: | 1.156 |
| Industry: | Drug Manufacturers - Specialty & Generic |
| Sector: | Healthcare |
| Employees: | 144 |
| IPO Date: | Nov 21, 2017 |
ZOM News
Zomedica posts record year-over-year revenue for 18th straight quarter! ANN ARBOR, MI / ACCESS Newswire / August 6, 2025 / Zomedica Corp. (OTCQB:ZOMDF) ("Zomedica" or the "Company"), a veterinary health company offering point-of-care diagnostic and therapeutic products for equine and companion animals, today reported consolidated financial results ... 8 days ago |
Company invites individual and institutional investors, as well as advisors and analysts, to attend online at VirtualInvestorConferences.com Company invites individual and institutional investors, as well as advisors and analysts, to attend online at VirtualInvestorConferences.com 9 days ago |
Engaging Sessions to Highlight Game-Changing Technologies, Expert Insights, and Growth Opportunities in Animal Health Featuring Zomedica Products ANN ARBOR, MI / ACCESS Newswire / May 19, 2025 / Zomedica Corp. (OTCQB:ZOMDF) ("Zomedica" or the "Company"), a veterinary health company offering point-of-care diagnostic and therapeutic products for equi... 2 months ago |
Zomedica Corp. (ZOMDF) came out with a quarterly loss of $0.02 per share versus the Zacks Consensus Estimate of a loss of $0.01. This compares to loss of $0.01 per share a year ago. 3 months ago |
ANN ARBOR, MI / ACCESS Newswire / May 15, 2025 / Zomedica Corp. (OTCQB:ZOMDF) ("Zomedica" or the "Company"), a veterinary health company offering point-of-care diagnostic and therapeutic products for equine and companion animals, today reported consolidated financial results for the first quarter ended March 31, 2025. "We are pleased with our perfo... 3 months ago |
Analyst Ratings